Benzinga | Nov 4, 2020 07:05AM EST

Aclaris Therapeutics Q3 EPS $(0.25) Up From $(0.56) YoY, Sales $1.45M Up From $983.00K YoY

Aclaris Therapeutics (NASDAQ:ACRS) reported quarterly losses of $(0.25) per share. This is a 55.36 percent increase over losses of $(0.56) per share from the same period last year. The company reported $1.45 million in sales this quarter. This is a 47.41 percent increase over sales of $983.00 thousand the same period last year.